Supplementary Figure 1.
Methylation-bias (M-bias) plots for whole-genome bisulfite sequencing samples. We plotted the mean methylation estimate for each position along our bisulfite converted sequencing reads to check for potential biases. The results for mate 1 and mate 2 reads were plotted separately. Little difference was observed in methylation estimates within an individual sample for bases from position 10 to 100. In both mates, reads containing a CpG site in the first 10 bases were excluded from the analysis since biases introduced during the end repair step of library preparation cause methylation estimates for these bases to vary based on position. The M-bias plot for the EBV transformed samples at day 16 and week 3 suggests that these two samples have a slight bias towards hypomethylation. Note that the conclusion in this manuscript is that these samples are not hypo-methylated throughout the genome. Validation of WGBS DMRs using bisulfite pyrosequencing. Bisulfite pyrosequencing was used to measure DNA methylation in EBV transformed, CD40 activated and quiescent B-cells in DMR regions identified by WGBS. Control reactions using 0%, 50%, 75% and 100% methylated DNA was performed to assess and verify the performance of the pyrosequencing assays. The plots on the right shows the WGBS data with the region chosen for pyrosequencing marked in red. This is the first of two figures showing pyrosequencing. Control reactions using 0%, 50%, 75% and 100% methylated DNA was performed to assess and verify the performance of the pyrosequencing assays. The plots on the right shows the WGBS data with the region chosen for pyrosequencing marked in red. This is the second of two figures showing pyrosequencing. * denominator is the number of non-N bases in the human, lambda phage, and EBV reference sequences (2,865,005,545) * denominator is the number of non-N bases in the human, lambda phage, and EBV reference sequences (2,865,005,545) * denominator is the number of non-N bases in the human, lambda phage, and EBV reference sequences (2,865,005,545) * denominator is the number of non-N bases in the human, lambda phage, and EBV reference sequences (2,865,005,545) * denominator is the number of non-N bases in the human, lambda phage, and EBV reference sequences (2,865,005,545) * denominator is the number of non-N bases in the human, lambda phage, and EBV reference sequences (2,865,005,545) * denominator is the number of non-N bases in the human, lambda phage, and EBV reference sequences (2,865,005,545) * denominator is the number of non-N bases in the human, lambda phage, and EBV reference sequences (2,865,005,545) * denominator is the number of non-N bases in the human, lambda phage, and EBV reference sequences (2,865,005,545) * denominator is the number of non-N bases in the human, lambda phage, and EBV reference sequences (2,865,005,545) * denominator is the number of non-N bases in the human, lambda phage, and EBV reference sequences (2,865,005,545)
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